Current Management and Treatment of Cerebral Vasospasm Complicating SAH

E-ISSN： 1996-3181|12|2|233-241

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.2, 2013-04, pp. : 233-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage

By Jain K.K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 859-870

Informa Healthcare

Access to resources Recommend Favorite

Endothelin and Subarachnoid Hemorrhage-Induced Cerebral Vasospasm: Pathogenesis and Treatment

Current Medicinal Chemistry, Vol. 11, Iss. 13, 2004-07 ,pp. : 1779-1791

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 843-852

Bentham Science Publishers

Access to resources Recommend Favorite

Sumatriptan: Cerebral vasospasm?: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

The management of dermatomyositis: current treatment options

By Sontheimer Richard D

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1083-1099

Informa Healthcare

Access to resources Recommend Favorite